Taken together, higher POSTN expression is associated with higher stromal infiltration and enhanced immune suppression in the tumor microenvironment, and attenuates immunotherapy efficacy in pancreatic cancer patients. The gene discussed is POSTN; the disease is familial pancreatic carcinoma.